Five GBM PDXs in the GC1118-sensitive group harbored an EGFR amplification, and two PDXs without amplification harbored gain-of-function EGFR mutations (V774M and T790M (B802), C636W (G542)). The gene discussed is EGFR; the disease is glioblastoma.